MicroRNAs in endometrial cancer

International Journal of Clinical Oncology

Volumn 18, Issue 2, 2013, Pages 186-192

  Banno, Kouji ^a   Yanokura, Megumi ^a   Kisu, Iori ^a   Yamagami, Wataru ^a   Susumu, Nobuyuki ^a   Aoki, Daisuke ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Endometrial cancer; Epigenetic; MicroRNA; miR 152; miR 34b

Indexed keywords

MICRORNA; MICRORNA 106B 25; MICRORNA 139; MICRORNA 145; MICRORNA 155; MICRORNA 17 92A; MICRORNA 1703P; MICRORNA 185; MICRORNA 191; MICRORNA 200C; MICRORNA 203; MICRORNA 204; MICRORNA 20A; MICRORNA 21; MICRORNA 210; MICRORNA 24; MICRORNA 25; MICRORNA 29B; MICRORNA 29C; MICRORNA 30B; MICRORNA 30D; MICRORNA 31; MICRORNA 34A; MICRORNA 34B; MICRORNA 34C; MICRORNA 451; MICRORNA 99A; POLYETHYLENEIMINE; TUMOR MARKER; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SURVIVAL; CARCINOGENESIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DNA METHYLATION; DOWN REGULATION; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SURVIVAL PREDICTION; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PROGNOSIS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84880919817     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-013-0526-9     Document Type: Review

References (42)

1. Yanokura M, Banno K, Kobayashi Y et al (2010) MicroRNA and endometrial cancer: roles of small RNAs in human tumors and clinical applications. Oncol Lett 1:935-940
2. Yanokura M, Banno K, Kisu I et al (2011) MicroRNA in endometrial cancer. Trends Cancer Res 7:49-55
3. Iorio MV, Croce CM (2012) Causes and consequences of microRNA dysregulation. Cancer J 18:215-222
4. Leal JA, Lleonart ME (2012) MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives. Cancer Lett [Epub ahead of print]
5. Toyota M, Suzuki H, Sasaki Y et al (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68:4123-4132
6. Tanaka N, Toyooka S, Soh J et al (2012) Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. Lung Cancer 76:32-38
7. Guo H, Hu X, Ge S et al (2012) Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation. Int J Biochem Cell Biol 44:1465-1472
8. Nishida N, Nagahara M, Sato T et al (2012) Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. Clin Cancer Res 18:3054-3070
9. Nardone A, Corvigno S, Brescia A et al (2011) Long-term cultures of stem/progenitor from lobular and ductal breast carcinomas under non-adherent conditions. Cytotechnology 63:67-80
10. Reinhart BJ, Slack FJ, Basson M et al (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901-906
11. Wang B, Zhang Q (2012) The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol 138:1659-1666
12. Liu R, Chen X, Du Y et al (2012) Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 58:610-618
13. Lin M, Gu J, Eng C et al (2012) Genetic variations in microRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin Cancer Res 18:3982-3991
14. Ryan BM, McClary AC, Valeri N et al (2012) Rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. PLoS ONE 7:e36306
15. Boeri M, Pastorino U, Sozzi G (2012) Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis. Cancer J 18:268-274
16. Jiang J, Sun X, Wang W et al (2012) Tumor microRNA-335 expression is associated with poor prognosis in human glioma. Med Oncol 29:3472-3477
17. Suzuki S, Yokobori T, Tanaka N et al (2012) CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma. Oncol Rep 28:465-472
18. Wang H, Chiu M, Xie Z et al (2012) Synthetic microRNA cassette dosing: pharmacokinetics, tissue distribution and bioactivity. Mol Pharm 9:1638-1644
19. Chistiakov DA, Chekhonin VP (2012) Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential. Eur J Pharmacol 684:8-18
20. Yang L, Li N, Wang H et al (2012) Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. Oncol Rep 28:592-600
21. Ru P, Steele R, Hsueh EC et al (2011) Anti-miR-203 upregulates SOCS3 expression in breast cancer cells and enhances cisplatin chemosensitivity. Genes Cancer 2:720-727
22. Chabot S, Pelofy S, Paganin-Gioanni A et al (2011) Electrotransfer of RNAi-based oligonucleotides for oncology. Anticancer Res 31:4083-4089
23. Kuokkanen S, Chen B, Ojalvo L et al (2010) Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod 82:791-801
24. Lessey BA (2010) Fine tuning of endometrial function by estrogen and progesterone through microRNAs. Biol Reprod 82:653-655
25. Toloubeydokhti T, Pan Q, Luo X et al (2008) The expression and ovarian steroid regulation of endometrial micro-RNAs. Reprod Sci 15:993-1001
26. Lin SC, Wang CC, Wu MH et al (2012) Hypoxia-induced microRNA-20a expression increases ERK phosphorylation and angiogenic gene expression in endometriotic stromal cells. J Clin Endocrinol Metab 97:E1515-E1523
27. Petracco R, Grechukhina O, Popkhadze S et al (2011) MicroRNA 135 regulates HOXA10 expression in endometriosis. J Clin Endocrinol Metab 96:E1925-E1933
28. Boren T, Xiong Y, Hakam A et al (2008) MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Gynecol Oncol 110:206-215
29. Wu W, Lin Z, Zhuang Z et al (2009) Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev 18:50-55
30. Chung TK, Cheung TH, Huen NY et al (2009) Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. Int J Cancer 124:1358-1365
31. Huang YW, Liu JC, Deatherage DE et al (2009) Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res 69:9038-9046
32. Banno K, Kisu I, Yanokura M et al (2012) Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice. Epigenomics 4:147-162
33. Tsuruta T, Kozaki K, Uesugi A et al (2012) miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. Cancer Res 71:6450-6462
34. Jiang F, Liu T, He Y et al (2011) MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo. BMC Cancer 11:425
35. Shang C, Lu YM, Meng LR (2012) MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2. Med Sci Monit 18:149-155
36. Xie Y, Wang YL, Yu L et al (2011) Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells. J Steroid Biochem Mol Biol 126:113-120
37. Zhou H, Xu X, Xun Q et al (2012) microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1. Oncol Rep 27:807-812
38. Chung TK, Lau TS, Cheung TH et al (2012) Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer 130:1036-1045
39. Karaayvaz M, Zhang C, Liang S et al (2012) Prognostic significance of miR-205 in endometrial cancer. PLoS ONE 7:e35158
40. Dong P, Kaneuchi M, Watari H et al (2011) MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer 10:99
41. Hiroki E, Suzuki F, Akahira JI et al (2012) MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma. Int J Cancer 131:E395-E404
42. Wu Y, Xiao Y, Ding X et al (2011) A miR-200b/200c/429-binding site polymorphism in the 3′ untranslated region of the AP-2α gene is associated with cisplatin resistance. PLoS ONE 6:e29043